Capstone: Integration, Simulation & Fellowship Readiness
Module Overview
Comprehensive integration of all learning through complex case management, multidisciplinary simulations, portfolio defense, and summative assessment. Preparation for IBD fellowship applications.
Benchmark Source: All Programs — Comprehensive Integration
Learning Objectives
Independently manage complex IBD patients across the full disease spectrum
Demonstrate all 10 EPAs at the level of supervised independence
Present a defended case portfolio and research project
Articulate a personal practice philosophy and career plan
Teaching Sessions
Complex Case Simulation Marathon
Eight complex IBD scenarios integrating all 11 modules — timed, assessed, debriefed in high-stakes format.
1Simulation Design & Logistics
Four-hour marathon simulating fellowship-graduate-level independent practice. Format: 8 stations × 25 minutes each (20 min scenario + 5 min immediate feedback) + 20 min mid-session break + 15 min closing debrief. Fellows rotate through stations in small groups of 2–3, with one active leader per case and peers observing. Faculty assessors at each station with standardized rubric (see assessment section). Standardized patients or high-fidelity mannequins for physical exam scenarios; EMR-style laptop for order entry; mock pharmacy for drug verification; shared decision-making scenarios with trained simulated patients/family members; remote consultation scenarios via video. Resources available: pre-approved clinical references (STRIDE-II, ECCO, AGA, Saudi MOH protocols, drug monographs)—closed-book except permitted references. Scenarios span full disease spectrum: acute severe colitis, complicated perianal CD, dysplasia management, pregnancy decision, transition visit, MDT case presentation, biologic failure, nutritional crisis. Pre-brief: simulation is a learning environment not punitive; errors are expected and are where growth happens; psychological safety explicitly framed. Post-brief (after each case): "plus/delta" structure—what went well, what could improve—followed by structured learning points. End-of-day debrief: fellow reflection on patterns, growth edges, commitments for practice.
Psychological safety is the single most important setup move. State it explicitly before the first case: "Errors are expected. This is a learning environment. Your assessment is on effort and reasoning, not perfection."
- 4-hour marathon, 8 stations × 25 min
- Standardized patients + mannequins + EMR + mock pharmacy
- Open-reference with pre-approved clinical resources
- Plus/delta debrief after each case
- Psychological safety explicitly framed
2Stations 1–4: Acute Scenarios
Station 1 — Acute Severe UC (ASUC): 28-year-old man presents with 12 bloody stools/day, HR 110, Hb 8.5, CRP 140, albumin 24. Tasks: admit, VTE prophylaxis, IV methylprednisolone, flex sig, stool cultures + CDI, day-3 assessment using Ho/Travis/Lindgren criteria, rescue therapy decision (infliximab accelerated vs cyclosporine), surgical consult trigger. Assessment: guideline adherence, timing, communication with patient and surgeon. Station 2 — Perianal Abscess with Fistula: 35-year-old woman with CD, new fluctuant perianal abscess, fever 39°C; tasks: exam under anesthesia coordination, MRI pelvis, antibiotics, drainage, then staged approach for fistula (seton + biologic), MDT referral. Station 3 — Severe Toxic Megacolon: 45-year-old woman with UC on biologic, 48h of increasing pain, distension, fever, WBC 22; abdominal X-ray shows transverse colon 9 cm with mucosal islands; tasks: NPO, NG, IV fluids, broad antibiotics, urgent surgical consult, weigh subtotal colectomy vs medical rescue (limited role); communication with patient/family about emergency surgery. Station 4 — Biologic Infusion Reaction: 30-year-old man on infliximab, second infusion, develops dyspnea, urticaria, BP drop during infusion; tasks: immediate discontinuation, ABC, epinephrine IM if severe, steroids/antihistamines, differentiate anaphylaxis vs serum sickness vs acute infusion reaction, plan future biologic (switch class) and communication with patient. Each station has scripted triggers, expected decision points, red-flag items, and "teaching pearls."
In ASUC, time is tissue. Every station assesses whether you recognize day-3 failure and escalate — hesitation here is the most common fellowship-level deficit.
- ASUC day-3 escalation decision must be automatic
- Perianal CD: exam + MRI + seton + biologic combined
- Toxic megacolon: surgical consult early, not salvage
- Infusion reaction: differentiate types, plan future biologic
- Communication scored alongside clinical decisions
3Stations 5–8: Outpatient & Multidisciplinary
Station 5 — Biologic Sequencing Failure: 38-year-old woman with CD, post-ileocolonic resection 3 years ago; has failed infliximab + azathioprine (secondary non-response), ustekinumab (primary non-response); now with Harvey-Bradshaw 9, CRP 30, calprotectin 800, MRE shows transmural recurrence; tasks: assess TDM (anti-drug antibody status, trough levels), select next agent (risankizumab? JAK? vedolizumab? surgery?), pre-treatment workup, counseling on realistic expectations, shared decision-making. Station 6 — Pregnancy Planning: 28-year-old Saudi woman with stable UC on infliximab 10 mg/kg q6w + azathioprine, planning pregnancy within 6 months; tasks: medication review (continue infliximab, continue azathioprine OR consider dose adjustment, confirm azathioprine tolerance with TPMT), vaccination review (update inactivated pre-pregnancy), folic acid 5 mg, nutritional review, discussion of placental transfer and infant live vaccine avoidance, plan for delivery and postpartum, spousal involvement if appropriate, Arabic patient education materials. Station 7 — Dysplasia Management: 52-year-old man with UC 22 years duration, Mayo 0 endoscopic, no PSC; surveillance chromoendoscopy identifies a 12 mm polypoid lesion cecum (Paris 0-IIa, Kudo Vi, NICE 3) with biopsies elsewhere showing no dysplasia; tasks: endoscopic resection feasibility assessment (EMR vs refer for ESD), tattoo, communication of risk and options (endoscopic vs colectomy), surveillance plan post-resection, MDT presentation; Saudi family involvement with individualized approach. Station 8 — MDT Case Presentation: fellow presents a pre-assigned index case (rotating among fellows) with structured SBAR format, handles MDT questions from simulated colorectal surgeon, radiologist, pathologist, IBD nurse, dietitian, psychologist; decision-making documented; plan articulated to patient/family. Assesses integration and leadership.
The MDT station is the truest test of fellowship readiness: can you present a complex case clearly, synthesize multi-specialty input, arrive at a decision, and own it with the patient?
- Biologic sequencing: TDM + evidence + cost + patient value
- Pregnancy: meds, vaccines, folic acid 5mg, family context
- Dysplasia: Paris/Kudo/NICE + EMR/ESD + MDT
- MDT presentation = integration test
- Saudi individualization throughout
4Assessment Rubric & Debrief Framework
Per-station rubric: (1) Data gathering (focused history, exam, investigations) — 5-point Likert; (2) Clinical reasoning (differential, synthesis) — 5-point; (3) Guideline-based decision-making — 5-point; (4) Communication (patient, family, colleagues) — 5-point; (5) Technical competence (where applicable) — 5-point; (6) Professionalism and time management — 5-point. Each domain mapped to EPAs (Entrustable Professional Activities) 1–10. Overall entrustability: 1 = requires constant supervision; 2 = supervised with frequent intervention; 3 = supervised but independent; 4 = unsupervised; 5 = capable of supervising. Fellowship-readiness target = 4 on most stations. Red-flag items (critical safety misses) = mandatory remediation. Standardized debrief framework (PEARLS — Promoting Excellence And Reflective Learning in Simulation): (1) react (emotional release, what stands out); (2) summarize (what happened clinically); (3) analyze with advocacy-inquiry ("I noticed X, I'm curious about your thinking"); (4) summarize learning points; (5) plan for practice. Written summary to each fellow with scores, narrative feedback, and specific commitments for next 6 months. Aggregate program-level data to identify curriculum gaps—if >50% of fellows struggle at a particular station, revise curriculum. Saudi adaptation: debriefs in preferred language (often mixed Arabic/English); respect hierarchical dynamics but ensure psychological safety for challenging upward; faculty modeling of vulnerability is key.
Simulation assessment is formative plus summative. The score matters less than the specific commitment to change — "I will do X differently next clinic" — that closes the learning loop.
- 6-domain rubric mapped to EPAs
- Entrustability target = 4 for fellowship graduation
- PEARLS debrief: react, summarize, analyze, learning, plan
- Red-flag items trigger remediation
- Aggregate data → curriculum refinement
5Post-Marathon Faculty Debrief & Remediation Planning
After the fellow marathon concludes, faculty hold a structured 60-minute debrief (closed-door, no fellows present). Agenda: (1) Station-by-station review — assessors share patterns observed, outliers, safety flags; consolidated scoring reviewed for calibration drift; inter-rater variability examined. (2) Individual fellow synthesis — each fellow discussed by cohort coordinator, with preliminary entrustability recommendation (level 1–5 on each of 10 EPAs); strengths highlighted before gaps; narrative written in standardized template. (3) Red-flag review — any mandatory remediation triggers (patient safety miss, professionalism lapse, communication breakdown) brought to full faculty for decision; documented with due process (written notice, opportunity to respond, remediation plan with timelines and reassessment criteria). (4) Cohort-level learning — what did the marathon reveal about curriculum? If >30% of fellows underperformed at a given station, root-cause analysis: was content not taught? taught poorly? assessed unfairly? Revise for next cohort. (5) Wellness check-in — simulation marathons are emotionally taxing for fellows; assessor team discusses which fellows may benefit from additional debrief, informal chat, or formal EAP referral. Saudi context: language used in narrative (Arabic/English/mixed) matches fellow preference; cultural context for decisions documented (e.g., family-involved case declined biologic = NOT competence gap, it is informed decision-making). Remediation pathways: (a) focused tutorial (2–4 hours on specific topic); (b) extra rotation (1–2 weeks supervised practice); (c) reassessment (mini-CEX or repeat station); (d) extended training (rare, formal with program director and SCFHS notification). All decisions final within 5 business days; fellows notified in-person with written follow-up.
A fair remediation is a gift, not a punishment. Frame it as "here is the specific gap and here is the specific support to close it" — never as a label.
- 60-min closed faculty debrief post-marathon
- Per-fellow narrative + EPA entrustability recommendation
- Red-flag items trigger due-process remediation
- Cohort data feeds curriculum revision
- Remediation = focused/rotation/reassessment/extended
- Eight-station simulation tests full-spectrum IBD readiness
- Acute scenarios (ASUC, toxic megacolon, perianal, infusion)
- Outpatient scenarios integrate TDM, pregnancy, dysplasia, MDT
- EPAs + entrustability scoring + PEARLS debrief
Portfolio Defense & Case Presentation
Each fellow defends their curated case portfolio — demonstrating all 10 EPAs through selected cases with structured faculty panel.
1Portfolio Content & EPA Mapping
Portfolio requirements (built over fellowship year, reviewed quarterly): (1) Minimum 20 diverse IBD cases with full documentation—demographics, phenotype (Montreal), presentation, workup, decisions, rationale, outcomes, reflection, EPA demonstrated. (2) Mapping to each of the 10 IBD EPAs: EPA 1 — new IBD diagnosis workup; EPA 2 — UC flare management including ASUC; EPA 3 — Crohn's complications management; EPA 4 — biologic initiation with pre-treatment workup; EPA 5 — dysplasia surveillance; EPA 6 — perianal disease management; EPA 7 — pregnancy and special populations; EPA 8 — MDT leadership; EPA 9 — SDM, psychosocial, nutrition; EPA 10 — QI/research contribution. Each case labeled to EPA(s). (3) Evidence of complexity—at least 5 cases rated "complex" by program director. (4) Outcomes tracked—symptom trajectory, biomarker response, adverse events. (5) Direct observation forms (DOPS, mini-CEX) from supervising faculty across the year. (6) Reflective writing for each case: 1 paragraph on "what I learned." (7) Patient feedback (anonymous post-visit surveys) compiled. (8) Imaging/endoscopy video clips where relevant. (9) MDT presentations catalog. (10) One case selected as "signature case" for oral defense—must demonstrate at least 3 EPAs. Format: electronic portfolio (PDF, REDCap repository, or department LMS); live-linked to EMR where privacy permits. Saudi context: PDPL-compliant de-identification; dual-language summary possible; spiritually sensitive handling of death/end-of-life cases.
A portfolio is not a scrapbook — every case must have a defensible EPA mapping and reflective commentary. Curate ruthlessly; quality over quantity after the 20-case minimum.
- 20+ diverse cases mapped to 10 EPAs
- Direct observations (DOPS, mini-CEX) integrated
- Reflective writing for each case
- Signature case for oral defense = 3+ EPAs
- PDPL de-identification + dual-language option
2Defense Format & Questioning
Defense structure (per fellow, 90 minutes total): (1) 15-minute signature case presentation—structured with SBAR or adapted IMRAD (Intro/Methods/Results/Discussion); show the case's complexity, decisions, evidence, and reflection. (2) 30-minute oral examination—panel of 3 faculty (IBD specialist, colorectal surgeon, nutritionist/psychologist or allied) rotate questions; domains covered: clinical reasoning (why did you choose X over Y?), evidence base (what trials inform this?), alternatives (what if the patient had refused biologic?), safety and risk (what could go wrong and how would you mitigate?), communication (how did you counsel the family?), system factors (how did the hospital workflow help or hinder?). (3) 15-minute broader portfolio review—panel questions on other cases, EPA demonstration, growth over the year. (4) 15-minute research/QI discussion—linked to Month 11 work. (5) 15-minute private panel deliberation + feedback. Panel decision: pass (ready for independent practice); pass with minor feedback; provisional pass (remediation assigned); fail (extended training required). Feedback delivered supportively; written summary sent within 48 hours. Saudi adaptation: panel ideally includes at least one female faculty member when female fellow defending; consider separate defense for patient confidentiality-sensitive signature cases (e.g., pregnancy loss, dysplasia). Recording with consent for program QI and trainee self-review.
The portfolio defense is as much a transition ritual as it is an exam. Approach it as an opportunity to reflect on the year, not just to prove competence.
- 15-min signature case + 30-min oral exam + 15-min portfolio + 15-min QI + 15-min feedback
- 3-member faculty panel (IBD + surgery + allied)
- Pass / pass with feedback / provisional / fail
- Written summary within 48h
- Gender-matched panel when preferred
3Sample Defense Questions & Common Pitfalls
High-yield sample questions fellows should be able to answer fluently: (1) Clinical reasoning — "Walk us through your differential for this new-onset bloody diarrhea and why CD was more likely than UC despite the left-sided distribution." (2) Evidence — "What is your trough level target for infliximab in fistulizing CD and why?" (cite TAXIT, PANIC, PAILOT). (3) Alternatives — "If this patient had refused biologics on religious grounds, what would your stepwise plan have been?" (4) Safety — "This patient developed a reactivation of latent TB on infliximab. What was missed at screening and how would you change your workflow?" (5) Communication — "Describe how you counseled this 22-year-old about lifelong biologic therapy and pregnancy planning." (6) Systems — "Your patient on vedolizumab flared after 6 missed infusions due to insurance issues. How would you engineer the clinic to prevent this?" (7) QI/research — "Present one metric from your personal dashboard and what you changed because of it." Common pitfalls: (a) defensiveness when challenged — panels are not attacking, they are probing depth; (b) over-citing studies without applying them to this specific patient; (c) failing to acknowledge a genuine miss in the case; (d) ignoring the psychosocial dimension; (e) generic answers to "why this program" in fellowship applications. Remediation if provisional pass: additional supervised cases in the weak domain, repeat defense in 3 months. Role-play sessions with senior fellows 1–2 weeks before defense reliably raise scores by 20–30%.
The panel is probing for how you think under pressure, not whether you know a fact. Reason aloud; show your working; honor genuine uncertainty.
- 7 high-yield question domains
- Defensiveness is the commonest pitfall
- Cite studies AND apply them to this patient
- Acknowledge genuine misses
- Role-play sessions raise scores 20-30%
4360-Degree Review & Peer Feedback Integration
Beyond the formal defense, a 360-degree review gathers perspectives from across the fellow’s sphere: (1) Faculty supervisors — attending evaluations from each rotation (IBD clinic, endoscopy, inpatient, MDT). (2) Allied health — IBD nurses, dietitians, psychologists, pharmacists rate communication, collaboration, respect. (3) Administrative staff — schedulers, receptionists rate professionalism, approachability, reliability with paperwork and dictations. (4) Peer fellows — anonymized mutual feedback on teamwork, knowledge sharing, reliability during call. (5) Patients — post-visit surveys (validated instrument, Arabic and English) on communication, empathy, explanation clarity, cultural sensitivity; Net Promoter Score tracked. (6) Self-assessment — fellow completes same rubric; discrepancies with others discussed in mentorship. Collection method: survey tool (REDCap or Microsoft Forms) with structured Likert + open comments; anonymous aggregation to protect respondents; minimum 15 raters across domains for validity. Analysis: radar chart showing scores across 6 domains (communication, collaboration, professionalism, reliability, knowledge application, empathy); compared to cohort average; qualitative themes extracted. Discussion: 45-minute mentorship meeting to review report, identify top 2 strengths and top 2 growth areas, develop action plan. Saudi adaptation: patient survey translated/validated in Arabic with cultural concepts (trust, modesty in communication, family involvement respect); gender-specific patient comments handled sensitively. Research shows 360 feedback, when well-implemented, is the single strongest predictor of post-training professionalism and patient outcomes — more than board scores or procedure logs. Use it seriously; act on it visibly.
The 360 is where the fellow discovers the gap between how they see themselves and how they are seen. Close that gap, and everything else improves.
- 6 rater groups: faculty, allied health, admin, peers, patients, self
- Validated Arabic+English patient survey
- Radar chart across 6 domains, cohort comparison
- Minimum 15 raters for validity
- Strongest predictor of post-training professionalism
- Portfolio = 20+ cases mapped to all 10 EPAs
- Signature case demonstrates 3+ EPAs
- Defense = presentation + oral exam + portfolio review + feedback
- Transition ritual, not just assessment
Research Project Presentation
Formal presentation of QI project or systematic review with Q&A from multidisciplinary audience and pathway to publication.
1Presentation Structure & Slide Design
Format: 20-minute presentation + 10-minute Q&A. Audience: faculty, co-fellows, research staff, invited regional colleagues (hybrid possible). Structure (IMRAD): (1) Title slide—project title, presenter, affiliation, date; (2) Background (2–3 slides)—clinical problem, local context, gap in knowledge or practice; (3) Aim and objectives—SMART statement; (4) Methods—design (QI vs SR vs RCT), setting, population, intervention, data sources, analysis plan, ethics approval; (5) Results—run charts for QI (showing baseline, intervention points, post-intervention), forest plots for SR/MA, tables for data summaries; (6) Discussion—interpretation, comparison to literature, strengths and limitations; (7) Conclusion—practice impact, policy implications, future research; (8) Acknowledgments and disclosures. Slide design principles: one key message per slide, minimal text (title + 3–5 bullet points max or single chart), high-quality images with sources cited, consistent font/color scheme, colorblind-safe palette, Arabic-English bilingual title slide for Saudi context. Avoid: text-heavy slides, jargon without definition, unexplained acronyms, low-resolution figures, reading verbatim from slides. Practice: dry run with co-fellows, timing check (20 minutes = 15–20 slides typically), prepare for likely questions. Use notes view for speaker reminders; presenter mode on remote.
One chart that tells the story beats three charts that don't. Your run chart or forest plot is probably THE slide people will remember — invest in making it beautiful.
- 20+10 format, IMRAD structure
- Run chart (QI) or forest plot (SR) = centerpiece slide
- One key message per slide, minimal text
- Bilingual title slide for Saudi audience
- Dry run with co-fellows mandatory
2Handling Q&A & Pathway to Publication
Q&A is often where projects are made or broken. Preparation: anticipate questions on methodology (why this design? power calculation? confounding?), generalizability (beyond your site?), policy implications, cost, comparison to published literature, "why didn't you..." critiques. Techniques: (1) listen fully before answering; (2) acknowledge the question ("Thank you, that's important"); (3) bridge to your prepared talking point if possible; (4) admit limitations honestly ("You're right, a limitation was..."); (5) differentiate "don't know" from "we didn't measure" from "it wasn't our primary aim"; (6) don't over-defend—partial agreement disarms hostility; (7) time management—keep answers <90 seconds usually, invite follow-up. Difficult questions: hostile reviewer (stay calm, thank, respond substantively); out-of-scope (acknowledge, redirect to relevant study); known weakness (acknowledge + mention planned next steps); opinion-only (state it as opinion, not data). Saudi cultural context: questioning from senior faculty may feel hierarchical—respond respectfully but confidently; female fellows may face additional challenges—faculty should intervene if questioning becomes inappropriate. Publication pathway: (1) target journal based on scope (Saudi J Gastroenterol for regional, BMJ Open Quality for QI, J Crohns Colitis for IBD science, Inflamm Bowel Dis); (2) convert presentation to manuscript using appropriate reporting standard (SQUIRE 2.0 for QI, PRISMA for SR, CONSORT for RCT, STROBE for observational); (3) IRB approval for publication if not already obtained; (4) co-authorship planning per ICMJE criteria; (5) submit abstract to DDW, ECCO, SGA annual meeting; (6) address peer reviewer comments respectfully and thoroughly. Timeline: aim for submission within 3 months of fellowship completion; final published paper within 12 months.
The highest-yield publication a fellow can produce is a well-executed QI project published in BMJ Open Quality with SQUIRE 2.0 reporting — it's internationally visible and shows every skill of independent practice.
- Q&A prep: anticipate method, generalizability, limits, alternatives
- Answer techniques: listen, acknowledge, bridge, admit, time
- SQUIRE 2.0 (QI), PRISMA (SR), CONSORT (RCT), STROBE
- Target journals: Saudi J Gastroenterol, BMJ Open Quality, J Crohns Colitis
- Submit abstract to DDW/ECCO/SGA annual meeting
3Visualization Standards & Slide Templates
Visualization choices make or break research presentations. Run chart (QI): x-axis = time (weeks or months), y-axis = metric, baseline median line, annotations for PDSA cycles, trend lines only after shift detected (≥6 consecutive points above/below median or ≥5 in a row trending). Use SPC software (QI Macros, R qcc) rather than Excel defaults. Forest plot (SR/MA): RevMan or R metafor; boxes sized by weight, lines for 95% CI, diamond for pooled effect, heterogeneity (I², τ²) in footer, separate subgroup estimates. Survival curve (cohort): Kaplan-Meier with shaded CI bands, at-risk table below, censoring ticks, log-rank p-value. Regression output: coefficient plot (point + CI) preferred over tables for >5 variables. Colorblind safety: avoid red-green contrast; use viridis, cividis, or ColorBrewer palettes; test with colorblind simulator. Fonts: sans-serif (Arial, Helvetica, Inter) ≥24pt on slides. Slide templates: SGA institutional template with Vision 2030 branding available; IBD Academy template; generic academic template. Bilingual slides: Arabic title on left, English on right for mixed audiences; reverse for Arabic-primary. Figure sourcing: cite every image (even icons); use CC-BY sources (BioRender, SMART Servier) or hand-draw; avoid Google Images. Embed vs link: embed videos/GIFs (don't rely on internet); compress images (<500 KB each); final deck <20 MB. Backup: PDF version + USB + cloud (OneDrive/Google Drive) + email to self. Rehearsal: 3 full run-throughs minimum, one with supervisor, one solo timed, one with naive audience.
Your run chart should be self-explanatory to someone who sees only that one slide. If it needs a verbal explanation, redesign it.
- Run chart = median line + SPC rules + PDSA annotations
- Forest plot via RevMan/metafor, not Excel
- Colorblind-safe palettes (viridis, ColorBrewer)
- Sans-serif ≥24pt; deck <20MB; 4-way backup
- 3 full rehearsals minimum
4Grant Writing, Dissemination & Research Sustainability
Most fellowship research dies at graduation because no funding pathway was planned. Build a 3-year research sustainability plan before finishing: (1) Grant landscape — Saudi opportunities (King Abdulaziz City for Science and Technology (KACST), King Salman Center for Disability Research, Saudi Ministry of Education research grants, Saudi Society of Gastroenterology research awards, King Abdullah International Medical Research Center (KAIMRC) for hospital-based work, Prince Naif bin Abdulaziz Health Research Center, Vision 2030 Health Sector Transformation funds); regional (Qatar National Research Fund, UAE Research Council); international (ACG Clinical Research Award, Crohn’s & Colitis Foundation Career Development Award, ECCO Grant, AGA Research Scholar Award, Takeda/Janssen/AbbVie investigator-initiated grants for industry-neutral questions). (2) Grant anatomy — specific aims (1 page, sharpest section), significance, innovation, approach (most weight), preliminary data, investigators, budget justification, timeline. (3) Budget components — personnel (PI effort, research coordinator, biostatistician), supplies (assay kits, software licenses), equipment, travel (conferences), publication fees, indirect costs (~25% negotiated). (4) Dissemination pyramid — peer-reviewed manuscript (apex), conference oral/poster (DDW, ECCO, UEG, ACG, regional SGA), society guidelines contribution, plain-language summary for patients, social media infographic (X/LinkedIn), podcast, local grand rounds, department noon conference. (5) Sustainability — register protocol with ClinicalTrials.gov or local trial registry (mandatory for many journals); plan data-sharing per journal/funder; build research team from Year 1 (statistician, research coordinator, nurse-researcher). (6) Ethical pipeline — IRB modifications handled proactively; authorship documented per ICMJE before data collection starts to avoid disputes; conflict-of-interest disclosures updated. Saudi context: align with Vision 2030 priorities (non-communicable disease, digital health, precision medicine, mental health) to maximize funding match; collaborate across MOH/NGHA/university silos; leverage Saudi IBD registry (OASIS/AMBER) for efficient cohort studies. Plan a publication per year for the first 3 post-fellowship years — this is the threshold for sustainable academic identity.
The fellow who writes a specific-aims page in their final month graduates with momentum; the one who doesn’t usually goes silent for 2 years.
- Saudi grants: KACST, KAIMRC, Vision 2030 health funds
- International: ACG, CCF, ECCO, AGA, industry-IIS
- Dissemination pyramid: paper → talk → infographic → podcast
- Register protocol + ICMJE authorship before data
- 1 paper/year for first 3 years = sustainable identity
- 20+10 IMRAD presentation with run chart/forest plot centerpiece
- Q&A = listen, acknowledge, bridge, admit limits
- Publication pathway: reporting standard + target journal + 3-month plan
- Fellowship-year QI publication = career differentiator
Fellowship Application Workshop
CV building, personal statement, interview prep, and letters of recommendation — for subspecialty fellowship and faculty applications.
1CV, Personal Statement & Portfolio Alignment
Academic CV structure: (1) personal details—name, contact, nationality (important for Saudi vs international programs), professional ID numbers (Saudi Commission for Health Specialties, medical licenses); (2) current position and institution; (3) education—reverse chronological, degrees, dates, institutions, grades/honors; (4) board certifications and training—Saudi SBIM, SGIL, international board (ABIM/EBGH as applicable); (5) clinical experience—brief, highlighting rotations and procedural competencies; (6) research experience—publications (PubMed-linked), presentations (oral vs poster, venues), grants, registry contributions, trial participation; (7) teaching experience—formal courses, lectures, mentorship; (8) quality improvement projects; (9) professional service—committees, peer review, society memberships (SGA, ACG, ECCO); (10) awards; (11) languages (Arabic native, English fluent, others); (12) references. Length: 4–8 pages academic; 1–2 pages non-academic. Saudi-specific: include Saudi board numbers, institutional affiliations with major centers (KFSHRC, KAMC, KFMC, KAUH, KSUMC), religious exemptions if any, Saudi Vision 2030-aligned activities. Personal statement (1–2 pages): narrative arc—(a) origin of interest in IBD (specific inspiring case or mentor), (b) training journey and formative experiences, (c) specific skills/accomplishments that set you apart, (d) goals (clinical, research, education), (e) why this specific fellowship program (tailor for each application), (f) what you will contribute. Show, don't tell—use specific cases, numbers, outcomes. Avoid: generic clichés, hyperbole, unsupported claims. Saudi applications may emphasize contribution to national health, Vision 2030 alignment, regional leadership potential.
Your personal statement's opening paragraph should be about a specific patient — not "I have always been fascinated by the complex interplay of..." Every reviewer has read 100 of the second; none forget the first.
- Academic CV 4–8 pages, reverse chronological
- PS 1–2 pages: story arc with specific patient opening
- Tailor PS to each program (1–2 lines specific to them)
- Saudi-specific: SCFHS numbers, Vision 2030 alignment
- Show don't tell — numbers, outcomes, specific cases
2Interview Preparation & Letters of Recommendation
Interview types: (1) structured (fixed questions, scored); (2) semi-structured; (3) conversational; (4) MMI (multiple mini-interviews, common in MedEd and some Saudi programs). Common IBD fellowship questions: (a) Tell me about yourself (2-minute rehearsed answer—chronological or thematic); (b) Why IBD? (specific patient and mentor story); (c) Why this program? (specific features: mentors, volume, research, surgical integration, MDT culture); (d) Tell me about a difficult case (use STAR format: Situation, Task, Action, Result); (e) Tell me about a failure (show insight, growth, change); (f) Tell me about a conflict (colleague, patient, system); (g) Research experience and plans (specific project, what you'd pursue); (h) Career goals (5-year, 10-year—clinical, research, leadership, geographic); (i) Clinical scenario (show reasoning, not just answer); (j) Questions for us (always prepare 3–5 thoughtful questions). Prep techniques: mock interviews with faculty and peers; record yourself; review common behavioral questions; prepare a "portfolio of stories" (6–8 specific anecdotes you can adapt). Interview-day: dress appropriately (conservative for Saudi context—full suit or equivalent modest professional attire; women should check program-specific expectations); arrive early; bring CV printouts, personal statement, research portfolio; stay engaged through tours and informal sessions (everyone evaluates). Letters of recommendation (LORs): (1) choose writers who know your work well (not just prestigious); (2) program director, IBD faculty mentor, research supervisor are classic triad; (3) request at least 6–8 weeks in advance; (4) provide each writer: CV, personal statement, list of activities with them, specific achievements to highlight, deadline, submission instructions; (5) follow up respectfully 2 weeks before deadline. Saudi context: some Saudi programs expect religiously appropriate phrasing in LOR (e.g., seeking Allah's blessing); international programs expect standard academic format. Diversity in letter writers strengthens application (clinical, research, educator).
Letter writers produce better letters when you give them ammunition. A one-page bullet list of what you accomplished together, with specific examples, doubles the quality of the letter you get.
- MMI increasingly common in Saudi programs
- Portfolio of 6–8 stories adapted to STAR format
- LORs: 3 writers, 6–8 weeks notice, full prep packet
- Dress conservative for Saudi context
- Saudi vs international LOR phrasing expectations
3Post-Fellowship Year 1 Plan & Mentorship
The first 12 months post-fellowship disproportionately shape a career. Structure a personal "Year-1 contract" with yourself: (1) Clinical — define patient panel (IBD-heavy? general GI + IBD clinic? hospital + MDT?); target case mix (new dx, flare, transition, pregnancy, dysplasia each quarter); procedural log continuation (chromoendoscopy, EUS-guided where applicable). (2) Academic — one peer-reviewed publication target (ideally fellowship project), one international conference presentation (DDW/ECCO/UEG), review 5–10 manuscripts as peer reviewer. (3) Teaching — at least 10 hours formal teaching (residents, medical students, junior colleagues), mentor one trainee. (4) QI — continue or start a new PDSA project with measurable aim. (5) Scholarship — SCFHS CPD 40 hours/year minimum; aim 80+. (6) Network — SGA membership and committee involvement; ACG and ECCO membership; regional IBD interest group. (7) Wellbeing — protected non-clinical time weekly, annual leave taken in full, peer-support network. Mentorship structure post-fellowship: maintain fellowship program director as informal mentor for 2 years; identify mid-career mentor in chosen subspecialty focus; identify peer mentor (same career stage, different institution) for mutual support. Write mentorship agreement: meeting frequency (monthly in year 1), goals, accountability. Sponsorship (distinct from mentorship) — ask a senior colleague to advocate for you for opportunities; be specific about what you want (speaker invitations, committee placements). Saudi context: leverage SGA, Saudi Commission for Health Specialties, MOH initiatives, Vision 2030 healthcare transformation; be visible in the region—Gulf IBD Working Group, Emirates Society of GI. International: apply for ACG International Travel Grant, ECCO Young GI Committee, Crohn's & Colitis Foundation fellowship programs. Financial: understand Saudi public (MOH, NGHA, university) vs private practice (Habib, Saudi German, Dr. Sulaiman Al Habib, DAP, Saudi British) vs consultant models; negotiate protected academic time (20% minimum).
Write your Year-1 plan on the first day of fellowship — and revise it every 3 months. Careers drift when nobody is steering.
- 7-domain Year-1 contract (clinical/academic/teaching/QI/CPD/network/wellbeing)
- Mentor + sponsor + peer mentor triad
- SGA + ACG + ECCO + regional GI engagement
- Protected academic time ≥20% negotiable
- Revise plan quarterly, not annually
4Contract Negotiation & Day-One Readiness
Negotiation happens once; the terms compound for a decade. Elements to negotiate (not just salary): (1) Salary — benchmark against Saudi Association of Medical Specialties salary survey, institutional pay scales (MOH unified scale vs private competitive), academic rank (assistant consultant vs consultant), equity if entering new institution. (2) Protected time — academic/research time (target 20–30% if academically oriented; specify "research day" in the week); education/teaching time; QI time. (3) Clinical load — number of clinics per week, inpatient weeks per year, call frequency and call pay differential. (4) Procedural time — endoscopy sessions per week, support for advanced procedures (chromoendoscopy, balloon enteroscopy, EUS if trained), equipment access. (5) Resources — office space, administrative support, dictation/EMR training, research coordinator, statistical support. (6) Professional development — annual CPD budget (target SAR 30,000–50,000), conference support (at least 1 international + 1 regional per year), sabbatical eligibility. (7) Benefits — health insurance (family coverage, dental, vision), life/disability insurance, retirement (GOSI + supplementary), paid leave (annual + sick + Hajj + maternity/paternity), housing allowance (if applicable), relocation support. (8) Performance and promotion — clear metrics for annual review, promotion criteria (academic track), pathway to consultant/senior consultant. (9) Exit terms — notice period (typically 3 months), non-compete clause scope (be cautious), intellectual property ownership, ability to take patients/data. Saudi-specific: Iqama sponsorship if non-Saudi; understanding of Saudization requirements; MOH vs NGHA vs university vs private distinctions. Day-one readiness: credentialing (Saudi Commission for Health Specialties license, institutional privileges, DEA-equivalent for controlled substances if applicable); EMR training; clinic template set-up (longer visits initially, space for complex new patients); first 30-day goals (meet key colleagues, understand referral patterns, identify 2–3 signature cases to introduce yourself). Negotiation etiquette: written offer, 7–14 days to consider, respectful counter once (not multiple), decline gracefully if accepting another offer. Tools: written offer letter reviewed by mentor AND lawyer before signing.
Everything is negotiable except the things you don’t ask about. Bring a checklist. Get every agreement in writing — verbal promises evaporate at signing.
- 9-domain negotiation checklist (salary, time, load, resources, benefits, exit)
- Protected academic time 20-30% for academic track
- Annual CPD budget target SAR 30-50k
- Review offer with mentor + lawyer
- 30-day onboarding goals: colleagues, workflow, signature cases
- CV + PS + LORs aligned and tailored to each program
- Personal statement opens with specific patient story
- Interview prep = portfolio of stories + mock interviews
- Letter writers need CV + PS + bullet-list of joint work
Summative Assessment & Graduation
Comprehensive MCQ exam, EPA milestone ratings, program exit interview, and graduation ceremony.
1Comprehensive MCQ Exam (100 questions)
Format: 100 single-best-answer MCQs over 2.5 hours (1.5 min/question average). Blueprint aligned to fellowship curriculum: Month 1 (Foundations & Epidemiology) 8%; Month 2 (Diagnostics) 10%; Month 3 (UC & CD Pathogenesis) 10%; Month 4 (Pharmacology) 14%; Month 5 (Treat-to-Target & Immunogenicity) 10%; Month 6 (Acute IBD) 10%; Month 7 (Endoscopy) 8%; Month 8 (Surgery) 8%; Month 9 (Special Populations) 8%; Month 10 (Holistic Care) 6%; Month 11 (Research & Quality) 4%; Month 12 (Integration) 4%. Question types: clinical vignettes (60%), mechanism/science (15%), guidelines-based decisions (15%), image interpretation (endoscopy, radiology, histology) (10%). Difficulty target: 65–80% mean for fellowship graduates. Pass threshold: typically 70% (modified Angoff method for standard setting). Allowed resources: none (closed book); bilingual (Arabic/English) option; extended time for disability accommodations. Sample questions cover: ASUC day-3 management; biologic selection in bio-exposed CD; interpreting Mayo score; PIANO data application in pregnancy counseling; Rutgeerts scoring post-ileocolonic anastomosis; shared decision for dysplasia management; recognition of infusion reaction types; TB screening thresholds. Post-exam: fellows receive domain-level scores to identify residual learning needs, feeding into final feedback and CPD planning. Failed exam: targeted remediation with re-sit within 3 months.
MCQ exams are least useful at identifying top performers and most useful at identifying gaps. Focus your post-exam energy on the 30% you got wrong — that's where next year's CME starts.
- 100 MCQs, 2.5 h, 70% pass threshold
- Blueprint aligned to all 12 months
- Clinical vignettes 60% + science/guidelines/images
- Bilingual option, disability accommodations
- Domain-level feedback → CPD plan
2EPA Milestone Assessment & Entrustability Decision
Final EPA assessment synthesizes the year's direct observations, case portfolio, simulation performance, and MCQ scores. For each of the 10 IBD EPAs, a panel (program director, IBD faculty mentor, surgical partner, IBD nurse, external examiner) assigns an entrustability level: 1 — requires constant direct supervision; 2 — requires frequent supervision with periodic check-ins; 3 — requires minimal supervision (senior-fellow level); 4 — independent practice (fellowship-graduate level); 5 — capable of supervising others. Graduation threshold: level 4 on all 10 EPAs OR level 4 on ≥8 EPAs with structured remediation plan for remaining. Rare level-5 ratings reserved for exceptional trainees with documented mentoring. Evidence sources: portfolio, DOPS (Direct Observation of Procedural Skills), mini-CEX (Mini-Clinical Evaluation Exercise), CBD (Case-Based Discussion), MSF (Multi-Source Feedback from peers, nurses, patients), simulation scores, MCQ, QI project, research output. Panel deliberates in private session, reviews evidence, debates discrepancies, arrives at consensus. Written EPA report delivered to each fellow: levels, narrative comments, specific strengths, areas for continued growth (even graduating fellows have growth edges), CPD recommendations for first 2 years of independent practice. Saudi context: align with Saudi Commission for Health Specialties (SCFHS) milestones; SCFHS now recognizes EPA-based assessment in IBD subspecialty tracks. Benchmark to international standards (ACGME, RCP UK, ECCO e-curriculum). Successful fellows receive completion certificate from SGA co-signed by program director and SCFHS representative; ineligible fellows receive structured extension plan.
EPA level 4 is the goal, but the real assessment is whether you'd consent to be the IBD patient of the fellow in question. That gut-level test aligns the panel faster than any rubric.
- 10 EPAs, 5-level entrustability scale
- Graduation = level 4 on all 10 (or 8 with remediation plan)
- Evidence synthesis: portfolio, DOPS, mini-CEX, MSF, MCQ, QI
- Align with SCFHS and international standards
- Certificate co-signed by SGA PD and SCFHS
3Exit Interview, CPD Plan & Practice Philosophy
Exit interview (60 minutes, program director 1:1): reflects on the year, fellow's self-assessment, career plan, program feedback (what worked, what didn't, what to change for next cohort), discussion of next steps. Fellow submits: (1) self-assessment of growth across the 10 EPAs; (2) 5-year career plan (clinical setting, research trajectory, leadership aspirations, geographic goals); (3) CPD plan for first 2 years of independent practice—courses, conferences (ECCO, ACG, DDW, SGA annual meeting minimum), journal memberships, online modules (ECCO e-curriculum, AGA university), mentorship relationships, peer network; (4) QI and research commitments (next project, publications in pipeline); (5) teaching and mentoring plans; (6) reflection essay (3–5 pages): "My IBD practice philosophy"—what patients deserve, what I commit to, my growth edges, how I will stay humble and curious, how I integrate faith/values with evidence-based practice (Saudi context). Program director provides: structured feedback, career advice, introductions to relevant mentors/faculty elsewhere, letters for future applications. Graduation ceremony: formal event at SGA annual meeting or institutional setting; family invited; certificates presented; program director address; graduate response (one fellow designated); dinner/reception; photographs. Saudi cultural touches: Quran recitation at opening, official speeches honoring royal patronage of medical education, family presence as key element of celebration, traditional hospitality (Arabic coffee, dates), tribal/familial acknowledgment where appropriate. Lifetime alumni network: SGA IBD fellowship alumni association—annual events, mentoring pipeline, research collaborations, future faculty pipeline for Saudi IBD training centers.
Your fellowship ends on graduation day, but your professional identity begins. Write your practice philosophy and put it where you'll see it every day. It will be the compass through the 30 years ahead.
- Exit interview: self-assessment, career, CPD, feedback
- 5-year plan + 2-year CPD commitments
- Practice philosophy essay (3–5 pages)
- Graduation ceremony with family + Saudi cultural elements
- Lifetime SGA IBD alumni network
4Faculty Calibration & Program Evaluation
A summative assessment is only as reliable as its assessors. Faculty calibration workshop held 2 weeks before exam: (1) all assessors review rubric and score 2–3 benchmark video cases together; inter-rater reliability calculated (target κ ≥0.6 for rubric items); divergent scorers re-trained. (2) EPA entrustability standards reviewed with case examples at each level (1 through 5). (3) Bias awareness—implicit bias training, gender/cultural/linguistic bias minimization; structured rubric adherence to reduce halo and recency effects. (4) Consensus protocols—disagreements >1 point resolved by discussion; if unresolved, third assessor independent score. Program-level evaluation (annual): (1) aggregate fellow performance data—pass rate, section scores, common weaknesses; (2) fellow exit surveys—curriculum strengths/gaps, faculty effectiveness, resource adequacy; (3) alumni 1-year and 5-year outcomes—publications, leadership positions, ongoing CPD, practice pattern analysis; (4) patient outcome linkage where feasible—fellow-led patient panels tracked via OASIS/AMBER for quality metrics (steroid-free remission, biologic optimization, readmissions); (5) benchmarking against international programs (Mayo, Cleveland Clinic, Oxford, St. Mark's). External review every 3 years by non-affiliated senior IBD faculty. CBAHI/JCI alignment for continued accreditation. Saudi Commission for Health Specialties program review. Curriculum revision cycle: minor updates annually (new evidence, new drugs); major revision every 5 years; emergency revision if safety concern identified. Feedback loop to trainees: annual report shared with current fellows showing aggregate anonymized data and changes made; transparency builds trust and engagement. Best-practice metric: fellowship program with ≥80% fellows reaching level-4 entrustability at graduation, ≥1 peer-reviewed publication per fellow, ≥90% employment in IBD-focused role within 6 months, ≥75% continued CPD participation at 5 years.
An assessment program without regular calibration produces scores that reflect assessors more than fellows. Calibrate, or stop assessing.
- Faculty calibration 2 weeks pre-exam (κ ≥0.6 target)
- Annual program evaluation + 3-year external review
- Benchmark vs Mayo, Cleveland, Oxford, St. Mark's
- 5-year best practice: 80% level-4, 1+ publication, 90% IBD employment
- Transparency loop to trainees
5Alumni Network, Lifelong Learning & Legacy
Fellowship does not end at the graduation certificate. Lifelong learning infrastructure: (1) Alumni network — formal SGA IBD Fellowship Alumni Group (WhatsApp + annual reunion + shared educational repository); mentorship role expected after 2 years (each senior alumnus commits to mentoring one current fellow); peer consultation for complex cases (case-of-the-week email chain, moderated). (2) Continuing Professional Development — SCFHS 40 hours/year minimum, 80+ hours recommended; structured self-study (UpToDate, DynaMed); formal CME activities (board reviews, society annual meetings, dedicated IBD courses like AIBD, Crohn’s & Colitis Congress, ECCO educational courses); simulation-based CME for maintenance of procedural skills; peer-reviewed publication and presentation. (3) Maintenance of Certification — SCFHS subspecialty recertification every 5 years (chart reviews, MOCA-style exams, CPD documentation); international certifications (ABIM MOC if applicable) parallel tracking; quality improvement project submission. (4) Teaching pipeline — give back by teaching current fellows (at least 4 formal sessions/year), medical students, residents; supervise at least 1 research project per year; develop teaching materials (cases, SIMs, slides) shared with program. (5) Advocacy — join SGA advocacy committee; engage with MOH on policy issues (biologic access, registry funding, care pathways); patient education initiatives (Ramadan fasting guidance, Hajj travel protocols, school/workplace advocacy). (6) Legacy project — define one signature contribution to the field over 10 years (a first-in-Saudi-Arabia clinical trial? a national quality improvement collaborative? a patient-support foundation? a textbook chapter? a teaching program?); this anchors career meaning. (7) Wellness sustainability — prevent burnout with built-in breaks, peer support, therapy if needed, family priority; lifelong GI career is a marathon. Saudi context: leverage unique position of being a founding generation of Saudi IBD specialists — document early experiences, mentor regional colleagues, shape national registries, engage diaspora networks. International: ECCO Fellowship Committee, ACG International Advisory Board, CCF Global Alliance — Saudi voice valuable in shaping equitable global IBD care.
Ten years from graduation, no one will remember your MCQ score. They will remember whether you built something, taught someone, and made the system better.
- SGA IBD Alumni Network: WhatsApp + reunion + mentorship
- SCFHS CPD 80+ hrs/yr; 5-year recertification
- Teaching pipeline: 4+ sessions/yr; mentor 1+ project
- Legacy project anchors 10-year career meaning
- Saudi founding-generation advantage globally
- 100-MCQ blueprint-aligned exam with domain feedback
- EPA level-4 on all 10 = graduation threshold
- Exit interview + 5-year career plan + 2-year CPD
- Practice philosophy essay anchors lifelong identity
Assessment
Summative MCQ (100 questions) + EPA milestone ratings + Portfolio defense + QI project
Clinical Pearls
Treat-to-target (STRIDE-II) should be your clinical compass: clinical + endoscopic + biomarker remission
Independent practice readiness means managing ANY IBD scenario
Your EPA portfolio is your proof of competency — document thoroughly
The field evolves rapidly — commit to lifelong learning through ECCO, ACG, and SGA
Practice Points
Prepare a case portfolio with at least 20 diverse IBD cases demonstrating all 10 EPAs
Practice mock interviews — common questions focus on difficult cases and career goals
Write a personal practice philosophy statement
Key References
Rubin DT, et al. ACG Clinical Guideline: UC in Adults. Am J Gastroenterol. 2019;114:384-413
Lichtenstein GR, et al. ACG Guideline: CD in Adults. Am J Gastroenterol. 2018;113:481-517
Turner D, et al. STRIDE-II Update. Lancet Gastroenterol Hepatol. 2021;6:171-185
Reading List
ACG Clinical Guidelines on UC
Rubin DT, et al. — Am J Gastroenterol (2019)
ACG Clinical Guidelines on CD
Lichtenstein GR, et al. — Am J Gastroenterol (2018)
ECCO Guidelines on Therapeutics in CD
Torres J, et al. — J Crohns Colitis (2020)
Fellowship application tips for IBD subspecialty
Bitton A, et al. — Inflamm Bowel Dis (2020)
